Patent Assignment
Reel/Frame 014337/0010
Security Interest
Recorded: 2004-02-12
Received: 2004-02-12
Pages: 20
Assignor
SYNX PHARMA INC.
Executed: 2004-02-09
Assignee
NANOGEN, INC.
10398 PACIFIC CENTER COURT, SAN DIEGO, CA, 92121, UNITED STATES
Covered Properties
(63)
Diagnostic methods for congestive heart failure
Application:
10/706,599 →
Method for identification of glycosylated polypeptides
Application:
10/461,004 →
Calibrator for Nt-Probnp Immunoassay
Application:
10/359,028 →
Polyclonal-monoclonal elisa assay for detecting n-terminus proBNP
Application:
10/359,051 →
Method for Retarding or Precluding Alzheimer's Dementia
Application:
10/334,701 →
Method of confirming the presence of myocardial infarction
Application:
10/325,162 →
Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP
Application:
10/300,733 →
Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP
Application:
10/299,977 →
Process for Determining the Presence of Monomeric Brain Associated Human Glutamine Synthetase in Patients Exhibiting Mild Cognitive Impairment
Application:
10/246,383 →
Amino Acid Sequence Pattern Matching
Application:
10/231,660 →
Diagnosis and treatment of dementia utilizing thrombospondin
Application:
10/032,229 →
Apolipoprotein biopolymer markers predictive of alzheimers disease
Application:
10/020,008 →
Ig Lambda Biopolymer Markers Predictive of Alzheimers Disease
Application:
09/991,797 →
Protein Biopolymer Markers Predictive of Type Ii Diabetes
Application:
09/993,393 →
Fragment of Plasma Protease C1 Inhibitor
Application:
09/991,799 →
Fibronectin Biopolymer Markers Indicative of Type Ii Diabetes
Application:
09/991,796 →
Protein Biopolymer Markers Predictive of Insulin Resistance
Application:
09/991,627 →
Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
Application:
09/991,795 →
Complement C3 precursor biopolymer markers related to Alzheimer's Disease
Application:
09/994,909 →
Fibronectin Precursor Biopolymer Markers Indicative of Alzheimer's Disease
Application:
09/993,289 →
Ig Heavy Chain, Ig Kappa, Ig Lambda Biopolymer Markers Predictive of Alzheimer's Disease
Application:
09/993,304 →
Apolipoprotein biopolymer markers indicative of type II diabetes
Application:
09/991,809 →
Complement C3 Precursor Biopolymer Markers Predictive of Type Ii Diabetes
Application:
09/993,287 →
Glycoprotein and apolipoprotein biopolymer markers indicative of Alzheimer's disease
Application:
09/993,344 →
Hp Biopolymer Markers Predictive of Insulin Resistance
Application:
09/991,800 →
Cene-E biopolymer marker indicative of age matched control
Application:
09/993,399 →
Biopolymer Markers Indicative of Type Ii Diabetes
Application:
09/993,300 →
Protein Biopolymer Markers Indicative of Insulin Resistance
Application:
09/993,392 →
Fibronectin Biopolymer Marker Indicative of Insulin Resistance
Application:
09/993,365 →
Protein Biopolymer Markers Indicative of Alzheimer's Disease
Application:
09/992,672 →
Complement C3 Precursor Biopolymer Markers Indicative of Insulin Resistance
Application:
09/993,290 →
Inter-Alpha Trypsin Inhibitor Biopolymer Marker Indicative of Insulin Resistance
Application:
09/993,295 →
Apolipoprotein Biopolymer Markers Indicative of Insulin Resistance
Application:
09/993,366 →
Betaine/Gaba Transport Protein Biopolymer Marker Indicative of Insulin Resistance
Application:
09/992,067 →
Method for Detecting the Presence of Monomeric Brain Associated Human Glutamine Synthetase
Application:
09/971,740 →
Diagnosis and treatment of early pre-type-1 diabetes utilizing glial fibrillary acidic protein
Application:
09/954,972 →
Conjunctive Analysis of Biological Marker Expression for Diagnosing Organ Failure
Application:
09/946,171 →
Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein
Application:
09/940,698 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1845 Daltons
Application:
09/846,351 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1521 Daltons
Application:
09/845,764 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 2753 Daltons
Application:
09/846,328 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1449 Daltons
Application:
09/846,349 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 2021 Daltons
Application:
09/846,344 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1097 Daltons
Application:
09/846,352 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1793 Daltons
Application:
09/845,739 →
Biopolymer marker indicative of disease state having a molecular weight of 1777 daltons
Application:
09/845,735 →
Method for monitoring and validating stress induction of disease state
Application:
09/846,341 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1348 Daltons
Application:
09/845,715 →
Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons
Application:
09/845,726 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1562 Daltons
Application:
09/845,738 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1865 Daltons
Application:
09/846,345 →
Biopolymer marker indicative of disease state having a molecular weight of 2056 daltons
Application:
09/845,736 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1350 Daltons
Application:
09/845,729 →
Biopolymer marker indicative of disease state having a molecular weight of 1998 daltons
Application:
09/846,346 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1211 Daltons
Application:
09/845,731 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1465 Daltons
Application:
09/845,719 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 2937 Daltons
Application:
09/846,329 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1896 Daltons
Application:
09/846,343 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1690 Daltons
Application:
09/845,730 →
Biopolymer marker indicative of disease state having a molecular weight of 1406 daltons
Application:
09/846,347 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 2267 Daltons
Application:
09/846,348 →
Biopolymer Marker Indicative of Disease State Having a Molecular Weight of 1206 Daltons
Application:
09/845,725 →
Process for Differential Diagnosis of Alzheimer's Dementia and Device Therefor
Application:
09/842,079 →